Adcock Ingram Holdings Ltd (AIP):企業の財務・戦略的SWOT分析

GlobalDataが発行した調査報告書(DATA904C9456)
◆英語タイトル:Adcock Ingram Holdings Ltd (AIP) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C9456
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年11月
◆ページ数:44
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:南アフリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,375見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,125見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Adcock Ingram Holdings Ltd (AIP) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Adcock Ingram Holdings Ltd (Adcock Ingram) develops, distributes and markets a wide range of healthcare products. The company’s product portfolio includes consumer and over-the-counter (OTC) products; prescription products; and generic medicines. It provides medicines in the areas of cardiovascular, central nervous system, cough, cold and flu, skin care, diabetes, ear, nose and eye preparations, feminine health, pain and respiratory diseases among others. Adcock Ingram also supplies critical care products, including blood collection products, intravenous solutions and renal dialysis systems. It operates three manufacturing facilities, namely, high volume liquids facility, tablet and capsule facility and critical care facility. The company supplies its products to both the private and public sectors of the market. Adcock Ingram is headquartered in Midrand, South Africa.

Adcock Ingram Holdings Ltd Key Recent Developments

Aug 29,2018: The Adcock Ingram reports a positive trading performance
Aug 29,2018: Adcock Ingram Holdings – Group annual results and cash dividend declaration
Jan 29,2018: Adcock Ingram Holdings: Change to the Board of Directors
Aug 25,2017: Adcock Ingram Group year-end results reflect a satisfying trading performance and exceptional increase in trading profits – as at 30 June 2017

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Adcock Ingram Holdings Ltd – Key Facts 6
Adcock Ingram Holdings Ltd – Key Employees 7
Adcock Ingram Holdings Ltd – Key Employee Biographies 8
Adcock Ingram Holdings Ltd – Major Products and Services 9
Adcock Ingram Holdings Ltd – History 10
Adcock Ingram Holdings Ltd – Company Statement 12
Adcock Ingram Holdings Ltd – Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Joint Venture 14
Section 2 – Company Analysis 15
Company Overview 15
Adcock Ingram Holdings Ltd – Business Description 16
Business Segment: Research and Development Services in India 16
Performance 16
Business Segment: Rest of Africa 16
Overview 16
Performance 16
Business Segment: Southern Africa 16
Overview 16
Performance 16
Adcock Ingram Holdings Ltd – Corporate Strategy 18
Adcock Ingram Holdings Ltd – SWOT Analysis 19
SWOT Analysis – Overview 19
Adcock Ingram Holdings Ltd – Strengths 19
Adcock Ingram Holdings Ltd – Weaknesses 20
Adcock Ingram Holdings Ltd – Opportunities 21
Adcock Ingram Holdings Ltd – Threats 22
Adcock Ingram Holdings Ltd – Key Competitors 23
Section 3 – Company Financial Ratios 24
Financial Ratios – Capital Market Ratios 24
Financial Ratios – Annual Ratios 25
Performance Chart 28
Financial Performance 28
Financial Ratios – Interim Ratios 29
Financial Ratios – Ratio Charts 30
Section 4 – Company’s Lifesciences Financial Deals and Alliances 31
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 32
Adcock Ingram Holdings Ltd, Recent Deals Summary 33
Section 5 – Company’s Recent Developments 34
Aug 29, 2018: The Adcock Ingram reports a positive trading performance 34
Aug 29, 2018: Adcock Ingram Holdings – Group annual results and cash dividend declaration 36
Jan 29, 2018: Adcock Ingram Holdings: Change to the Board of Directors 38
Aug 25, 2017: Adcock Ingram Group year-end results reflect a satisfying trading performance and exceptional increase in trading profits – as at 30 June 2017 39
Section 6 – Appendix 40
Methodology 40
Ratio Definitions 40
About GlobalData 44
Contact Us 44
Disclaimer 44

List of Tables
Adcock Ingram Holdings Ltd, Key Facts 6
Adcock Ingram Holdings Ltd, Key Employees 7
Adcock Ingram Holdings Ltd, Key Employee Biographies 8
Adcock Ingram Holdings Ltd, Major Products and Services 9
Adcock Ingram Holdings Ltd, History 10
Adcock Ingram Holdings Ltd, Subsidiaries 13
Adcock Ingram Holdings Ltd, Joint Venture 14
Adcock Ingram Holdings Ltd, Key Competitors 23
Adcock Ingram Holdings Ltd, Ratios based on current share price 24
Adcock Ingram Holdings Ltd, Annual Ratios 25
Adcock Ingram Holdings Ltd, Annual Ratios (Cont...1) 26
Adcock Ingram Holdings Ltd, Annual Ratios (Cont...2) 27
Adcock Ingram Holdings Ltd, Interim Ratios 29
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 32
Adcock Ingram Holdings Ltd, Recent Deals Summary 33
Currency Codes 40
Capital Market Ratios 40
Equity Ratios 41
Profitability Ratios 41
Cost Ratios 42
Liquidity Ratios 42
Leverage Ratios 43
Efficiency Ratios 43

List of Figures
Adcock Ingram Holdings Ltd, Performance Chart (2014 - 2018) 28
Adcock Ingram Holdings Ltd, Ratio Charts 30
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 32

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Adcock Ingram Holdings Ltd (AIP):企業の財務・戦略的SWOT分析(Adcock Ingram Holdings Ltd (AIP) - Financial and Strategic SWOT Analysis Review)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆